BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 17510977)

  • 1. Amyloid beta protein-related death-inducing protein induces G2/M arrest: Implications for neurodegeneration in Alzheimer's disease.
    Lakshmana MK; Hara H; Tabira T
    J Neurosci Res; 2007 Aug; 85(10):2262-71. PubMed ID: 17510977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta peptide binds a novel death-inducing protein, AB-DIP.
    Lakshmana MK; Araki W; Tabira T
    FASEB J; 2005 Aug; 19(10):1362-4. PubMed ID: 15923395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner.
    Stewart ZA; Tang LJ; Pietenpol JA
    Oncogene; 2001 Jan; 20(1):113-24. PubMed ID: 11244509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism.
    Petratos S; Li QX; George AJ; Hou X; Kerr ML; Unabia SE; Hatzinisiriou I; Maksel D; Aguilar MI; Small DH
    Brain; 2008 Jan; 131(Pt 1):90-108. PubMed ID: 18000012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest.
    Rong R; Jin W; Zhang J; Sheikh MS; Huang Y
    Oncogene; 2004 Oct; 23(50):8216-30. PubMed ID: 15378022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
    Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
    Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thr 446 phosphorylation of PKR by HCV core protein deregulates G2/M phase in HCC cells.
    Alisi A; Mele R; Spaziani A; Tavolaro S; Palescandolo E; Balsano C
    J Cell Physiol; 2005 Oct; 205(1):25-31. PubMed ID: 15880455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.
    Whang YM; Park KH; Jung HY; Jo UH; Kim YH
    Cancer; 2009 Mar; 115(6):1253-66. PubMed ID: 19156899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
    Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
    Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
    Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
    J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of protein kinase PKN1 in G2/M delay caused by arsenite.
    Isagawa T; Takahashi M; Kato T; Mukai H; Ono Y
    Mol Carcinog; 2005 May; 43(1):1-12. PubMed ID: 15791647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide (1-42).
    Qin Z; Sun Z; Huang J; Hu Y; Wu Z; Mei B
    Neurosci Lett; 2008 Oct; 444(3):217-21. PubMed ID: 18760331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
    Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of HSP27 phosphorylation induced by microtubule interfering agents: implication of p38 signalling pathway.
    Casado P; Zuazua-Villar P; Prado MA; Valle ED; Iglesias JM; Martínez-Campa C; Lazo PS; Ramos S
    Arch Biochem Biophys; 2007 May; 461(1):123-9. PubMed ID: 17367746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrotubule agents can activate different apoptotic pathways].
    Kisurina-Evgen'eva OP; Briantseva SA; Stil' AA; Onishchenko GE
    Biofizika; 2006; 51(5):875-9. PubMed ID: 17131827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK.
    Moon DO; Kim MO; Kang SH; Lee KJ; Heo MS; Choi KS; Choi YH; Kim GY
    Biochem Pharmacol; 2008 Aug; 76(3):312-21. PubMed ID: 18571148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway.
    Hsu TS; Chen C; Lee PT; Chiu SJ; Liu HF; Tsai CC; Chao JI
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):799-808. PubMed ID: 18193228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis.
    Higginbottom K; Jahnke U; Newland AC; Cotter FE; Allen PD
    Apoptosis; 2007 Oct; 12(10):1847-55. PubMed ID: 17636382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Gan PP; Pasquier E; Kavallaris M
    Cancer Res; 2007 Oct; 67(19):9356-63. PubMed ID: 17909044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.